AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. Astellas Pharma Inc.
  3. Financials
  4. Net income margin (%)

Astellas Pharma Inc.【JP:4503】

Market cap
¥4.57T
P/E ratio
18.1x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndNet income margin (%) YoY (%)
Mar 31, 20252.7+149.67%
Mar 31, 20241.1-83.65%
Mar 31, 20236.5-32.10%
Mar 31, 20229.6-0.80%
Mar 31, 20219.7-35.76%
Mar 31, 202015-11.71%
Mar 31, 201917+34.35%
Mar 31, 201812.7-24.04%
Mar 31, 201716.7+18.17%
Mar 31, 201614.1+29.54%
Mar 31, 201510.9+39.58%
Mar 31, 20147.8-15.13%
Mar 31, 20139.2+135.63%
Mar 31, 20123.9

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)